Pharmaceutical firms to improve deferred accounts receivable portfolios
Domestic pharmaceutical firms are making desperate efforts to shorten the settlement period of their deferred accounts receivables in a bid to cope with protracted business slump and create better management conditions.
Business sources said that a lot of pharmaceutical companies have ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
